Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. Long Term Debt 2017–2025
Arcus Biosciences Inc. annual/quarterly long term debt history from 2024 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Arcus Biosciences Inc. long term debt for the quarter ending December 31, 2025 were 99.0M, a 106.25% increase year-over-year.
- Arcus Biosciences Inc. long term debt for 2025 were 99.0M, a 106.25% increase from 2024.
- Arcus Biosciences Inc. long term debt for 2024 were 48.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arcus Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $99 |
| 2024 | $48 |
| Arcus Biosciences Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $99 |
| 2024-12-31 | $48 |
Arcus Biosciences Inc. Long Term Debt — FAQ
Arcus Biosciences Inc. (RCUS) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RCUS's long term debt history?
The chart and table above show Arcus Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.